Pharmaceutical products

Country: France
Language: EN FR
Customer: CHU de Bordeaux
Number: 4229110
Publication date: 13-09-2017
Source: TED
Descripition in original language
Tags: Pharmaceutical products electrotechnical, electronic and electromechanical equipment

Description

  1. Section I
    1. Name and addresses
      CHU de Bordeaux
      Unité d"achat des médicaments du CHU de Bordeaux, 12 rue Dubernat
      Talence Cedex
      33404
      France
      Telephone: +33 557656284
      E-mail: pharmacie.sud@chu-bordeaux.fr
      Fax: +33 557656459
    2. Type of the contracting authority:
      Body governed by public law
    3. Main activity:
      Health
  2. Section II
    1. Scope of the procurement:
      1. Title:

        Fourniture de médicaments: Atosiban — Terlipressine — Infliximab — Etanercept, au groupement de commande des CHU et principaux CH — HMG18.


        Reference number: 17MEDFNA136
      2. Main CPV code:
        33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000
      3. Type of contract:
        Supplies
      4. Short description:

        Fourniture de médicaments: Atosiban — Terlipressine — Infliximab — Etanercept, au groupement de commande des CHU et principaux CH — HMG18.


      5. Information about lots:
        This contract is divided into lots: yes
      6. Total value of the procurement:
        Value excluding VAT: 1.00 EUR
    2. Description
      1. Title:

        Atosiban inj


      2. Additional CPV code(s):
        33600000
      3. Place of performance:
        Main site or place of performance:

        Pharmacies des CHU et principaux CH.


      4. Description of the procurement:

        Sl1: faible dosage — qté est. 1ère période: 6 392 / sl 2: fort dosage — qté est. 1ère période: 51 529.


      5. Award criteria:
        Quality criterion - Name: 1. Intérêt thérapeutique et technique: 1a. Présentation 10 pts — 1b. Facilité d"utilisation 10 pts — 1c. Composition 10 pts / Weighting: 30
        Price - Weighting: 70
      6. Information about options:
        Options: no
      7. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      8. Additional information:
      9. Title:

        Etanercept inj usage pédiatrique


      10. Additional CPV code(s):
        33600000
      11. Place of performance:
        Main site or place of performance:

        Pharmacies des CHU et principaux CH.


      12. Description of the procurement:

        Sl 1: inj 10mg flacon ou équivalent — qté est. 1ère période: 37 / sl 2: inj 25mg flacon ou équivalent — qté est. 1ère période: 34 / sl 3: inj 25mg seringue pré-remplie ou équivalent — qté est. 1ère période: 177.


      13. Award criteria:
        Quality criterion - Name: 1. Intérêt thérapeutique et technique: 1a. Présentation du produit 12 pts — 1b. Contribution au bon usage du produit 38 pts / Weighting: 50
        Price - Weighting: 50
      14. Information about options:
        Options: no
      15. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      16. Additional information:
      17. Title:

        Etanercept inj usage adulte


      18. Additional CPV code(s):
        33600000
      19. Place of performance:
        Main site or place of performance:

        Pharmacies des CHU et principaux CH.


      20. Description of the procurement:

        Sl 1: inj 25mg flacon ou équivalent — qté est. 1ère période: 53 / sl 2: inj 25mg seringue pré-remplie ou équivalent — qté est. 1ère période: 725 / sl 3: inj 50mg seringue pré-remplie ou équivalent: qté est. 1ère période: 313 / sl 4: inj 50mg stylo ou équivalent — qté est. 1ère période: 155.


      21. Award criteria:
        Quality criterion - Name: 1. Intérêt thérapeutique et technique: 1a. Présentation du produit 12 pts — 1b. Contribution au bon usage du produit 38 pts / Weighting: 50
        Price - Weighting: 50
      22. Information about options:
        Options: no
      23. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      24. Additional information:
      25. Title:

        Infliximab inj pour les traitements de 1° intention des patients


      26. Additional CPV code(s):
        33600000
      27. Place of performance:
        Main site or place of performance:

        Pharmacies des CHU et principaux CH.


      28. Description of the procurement:

        Sl 1: 100mg flacon — qté est. 1ère période: 160 977.


      29. Award criteria:
        Quality criterion - Name: 1. Intérêt thérapeutique et technique: 1a. Présentation du produit 25 pts — 1b. Contribution au bon usage du produit 35 pts / Weighting: 60
        Price - Weighting: 40
      30. Information about options:
        Options: no
      31. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      32. Additional information:
      33. Title:

        Infliximab inj pour les traitements de 2° intention des patients


      34. Additional CPV code(s):
        33600000
      35. Place of performance:
        Main site or place of performance:

        Pharmacies des CHU et principaux CH.


      36. Description of the procurement:

        Sl 1: 100mg flacon — qté est. 1ère période: 119 942.


      37. Award criteria:
        Quality criterion - Name: 1. Intérêt thérapeutique et technique: 1a. Présentation du produit 25 pts — 1b. Contribution au bon usage du produit 35 pts / Weighting: 60
        Price - Weighting: 40
      38. Information about options:
        Options: no
      39. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      40. Additional information:
      41. Title:

        Terlipressine inj


      42. Additional CPV code(s):
        33600000
      43. Place of performance:
        Main site or place of performance:

        Pharmacies des CHU et principaux CH.


      44. Description of the procurement:

        Sl 1: inj 1mg — qté est. 1ère période: 29 444.


      45. Award criteria:
        Quality criterion - Name: 1. Intérêt thérapeutique et technique: 1a. Présentation 10 pts — 1b. Facilité d"utilisation 10 pts — Composition 10 pts / Weighting: 30
        Price - Weighting: 70
      46. Information about options:
        Options: no
      47. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      48. Additional information:
  3. Section IV
  4. Description:
    1. Type of procedure:
      Open procedure
    2. Information about a framework agreement or a dynamic purchasing system:
      The procurement involves the establishment of a framework agreement
    3. Information about electronic auction:
    4. Information about the Government Procurement Agreement (GPA):
      The procurement is covered by the Government Procurement Agreement: yes
  5. Administrative information:
    1. Previous publication concerning this procedure:
      Notice number in the OJ S: 2017/S 107-214827
    2. Information about termination of dynamic purchasing system:
    3. Information about termination of call for competition in the form of a prior information notice:
  1. Lot No: 1
    Title:

    Atosiban inj


  2. Award of contract
    1. Date of conclusion of the contract: 2017-08-10
    2. Information about tenders:
      Number of tenders received: 3
      The contract has been awarded to a group of economic operators: no
    3. Name and address of the contractor:
      csp
      76 avenue du midi cs 30077
      Cournon Cedex
      63802
      France
      The contractor is an SME: no
    4. Information on value of the contract/lot (excluding VAT):

      Total value of the contract/lot: 1.00 EUR
    5. Information about subcontracting:

      Lot No: 2
      Title:

      Etanercept inj usage pédiatrique


    6. Award of contract
      1. Date of conclusion of the contract: 2017-08-10
      2. Information about tenders:
        Number of tenders received: 1
        The contract has been awarded to a group of economic operators: no
      3. Name and address of the contractor:
        pfizer sas
        23-25 av du docteur lannelongue
        Paris Cedex 14
        75668
        France
        The contractor is an SME: no
      4. Information on value of the contract/lot (excluding VAT):

        Total value of the contract/lot: 1.00 EUR
      5. Information about subcontracting:

        Lot No: 3
        Title:

        Etanercept inj usage adulte: lot déclaré sans suite pour motif d"intérêt général (défaut de concurrence)


        Lot No: 4
        Title:

        Infliximab inj pour les traitements de 1° intention des patients


      6. Award of contract
        1. Date of conclusion of the contract: 2017-08-10
        2. Information about tenders:
          Number of tenders received: 4
          The contract has been awarded to a group of economic operators: no
        3. Name and address of the contractor:
          pfizer sas
          23-25 av du docteur lannelongue
          Paris Cedex 14
          75668
          France
          The contractor is an SME: no
        4. Information on value of the contract/lot (excluding VAT):

          Total value of the contract/lot: 1.00 EUR
        5. Information about subcontracting:

          Lot No: 5
          Title:

          Infliximab inj pour les traitements de 2° intention des patients


        6. Award of contract
          1. Date of conclusion of the contract: 2017-08-10
          2. Information about tenders:
            Number of tenders received: 4
            The contract has been awarded to a group of economic operators: no
          3. Name and address of the contractor:
            msd france
            34 avenue leonard de vinci
            Courbevoie Cedex
            92418
            France
            The contractor is an SME: no
          4. Information on value of the contract/lot (excluding VAT):

            Total value of the contract/lot: 1.00 EUR
          5. Information about subcontracting:

            Lot No: 6
            Title:

            Terlipressine inj


          6. Award of contract
            1. Date of conclusion of the contract: 2017-08-10
            2. Information about tenders:
              Number of tenders received: 2
              The contract has been awarded to a group of economic operators: no
            3. Name and address of the contractor:
              csp
              76 avenue du midi cs 30077
              Cournon Cedex
              63802
              France
              The contractor is an SME: no
            4. Information on value of the contract/lot (excluding VAT):

              Total value of the contract/lot: 1.00 EUR
            5. Information about subcontracting:

        7. Section VI
          1. Additional information

            Suite du I.1): suite du listing des autres pouvoirs adjudicateurs pour le compte duquel le CHU de Bordeaux agit:

            CH d"aix-pertuis — cH d"ancenis — gapm carcassonne -chi Compiègne-Noyon — cH Côte de Lumière — ch

            digne les bains — ch douarnenez — ch doullens — cHI Eure et Seine — gH La Rochelle — cH

            LIBOURNE — cH Loire Vendée Océan — ch moulins-yzeure — cHU de Poitiers — ch pontoise — cH de

            quimper — cHU de Reims — cHU de Rennes — cHU de la Réunion — cHU de Rouen — cHU de Saint Etienne — ch

            saint quentin — gCS Sant"Estuaire (CH Le Havre et CH de la Risle) — ch sarreguemines — hôpitaux

            Universitaires de Strasbourg — cH de Toulon-La-Seyne-Sur-Mer — cHU de Toulouse — cHU de Tours — cH de

            troyes — centrale d"achats Uniha.


          2. Procedures for review
            1. Review body
              tribunal administratif de Bordeaux
              9 rue Tastet — bP 947
              Bordeaux Cedex
              33063
              France
              Telephone: +33 556993800
              E-mail: greffe.tabordeaux@juradm.fr
            2. Body responsible for mediation procedures
              comité consultatif interrégional de règlement amiable des marchés publics de Bordeaux (CCIRA de Bordeaux)
              103 bis rue Belleville — bP 952
              Bordeaux Cedex
              33063
              France
              Telephone: +33 557019751
              E-mail: jeanlouis.barbaud@directe.gouv.fr
            3. Service from which information about the review procedure may be obtained

              Les candidats pourront saisir le juge administratif:

              — par un référé pré contractuel dans un délai de 11 jours à compter de la date d"envoi de la décision de ne pas les retenir;

              — par un référé contractuel dans un délai de 31 jours suivant les modalités d"accomplissement de publicité.

              Tout tiers au contrat peut introduire un recours en contestation de validité du contrat dans un délai de deux mois suivant les modalités d"accomplissement de publicité.


              tribunal administratif de Bordeaux
              9 rue Tastet — bP 947
              Bordeaux Cedex
              33063
              France
              Telephone: +33 556993800
              E-mail: greffe.tabordeaux@juradm.fr
              Fax: +33 556243903
          3. Date of dispatch of this notice
            2017-09-08

Other tenders from France за for this period

Food, beverages, tobacco and related products Source: TED

Floor-cleaning machines Source: TED

Floor-cleaning machines Source: TED

Floor-cleaning machines Source: TED

Floor-cleaning machines Source: TED